MedWatch

RNA pioneer left top job in favor of start-up: "The time was right"

For CEO in Genevant Sciences, Bo Rode Hansen, it needed careful consideration to resign from his job as Global Head of RNA Therapeutics in Roche and General Manager of Roche Innovation Center Copenhagen in favor of the biotech start-up on the US East Coast.

Foto: Privat

Back in April, Bo Rode Hansen surprised his employers when he announced his resignation from his position as Global Head of RNA Therapeutics in Swiss drug group Roche and General Manager of Roche Innovation Center Copenhagen.

Instead, an attractive and exciting CEO position in a new start-up brought the Danish biochemist to the US biotech hub Boston.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier